gold has been researched along with Glioblastoma in 85 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.18) | 18.7374 |
| 1990's | 1 (1.18) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 42 (49.41) | 24.3611 |
| 2020's | 41 (48.24) | 2.80 |
| Authors | Studies |
|---|---|
| Bostoën, M; Chevance, S; Éliat, PA; Gauffre, F; Goubault, C; Guillaudeux, T; Jarry, U; Kahn, ML; Pedeux, R | 1 |
| Huang, WT; Jang, D; Kim, DH; Kim, M; Kim, S; Lee, H; Liu, RS; Marques Mota, F; Yu, S; Yuan, H | 1 |
| Belchior, A; Campello, MPC; Carvalho, J; Cruz, C; D'Onofrio, A; Di Maria, S; Marques, A; Marques, F; Mendes, C; Oliveira, MC; Paulo, A; Pinto, C; Raposinho, P; Silva, F | 1 |
| Chu, L; Liu, X; Sha, C; Sun, K; Sun, Y; Wang, A; Wang, S; Xu, L; Yang, X; Yu, Y; Zhou, L | 1 |
| Fermi, V; Herold-Mende, C; Regulska, E; Romero-Nieto, C; Rominger, F; Wessling, P; Wolfram, A | 1 |
| Boukos, N; Chalmpes, N; Corral, CA; Efthimiadou, EK; Gobbo, OL; Gournis, D; Papanastasiou, G; Sakellis, E; Stavropoulou, AP; Tavares, A; Theodosiou, M; Wang, C | 1 |
| Fay, AP; Guerra, DB; Morrone, FB; Oliveira, EMN; Papaléo, RM; Sbaraine, P; Sonntag, AR | 1 |
| Cândido, MA; Castilho, M; Jesus, V; Pacheco-Soares, C; Raniero, L; Vieira, P | 1 |
| Karmakar, S; Kaundal, B; Roy Choudhury, S | 1 |
| Bearzi, C; Calogero, A; Chirivì, M; De Falco, E; De Sio, L; Miglietta, S; Pani, R; Perotto, G; Petronella, F; Petrozza, V; Rizzi, R; Rosa, P | 1 |
| Ju, FN; Kim, CD; Kim, CH; Kim, TH; Lee, KH; Lee, T; Lim, J; Park, CG | 1 |
| Bazzi, R; Chastagner, P; Chateau, A; Devy, J; Durand, M; Jubréaux, J; Laurent, G; Paquot, H; Pinel, S; Reinhard-Ruch, A; Richet, N; Roux, S | 1 |
| Al-Jamal, KT; Dickson, W; Griffiths, A; Han, S; Liam-Or, R; Rouatbi, N; Sosabowski, J; Utami, RN; Wang, JT; Yavuz, E; Zam, A | 1 |
| Ara, MHM; Heydari, E; Jalali, BK; Karimzadeh-Bardeei, L; Shik, SS | 1 |
| Boyd, M; Faulds, K; Graham, D; McCabe, SM; Shand, NC; Sloan-Dennison, S; Tipping, WJ; Wallace, GQ | 1 |
| Bazzi, R; Butterworth, KT; Dabaja, I; Duffy, D; Hutchinson, A; Kerr, BN; McInerney, CE; Prise, KM; Roux, S | 1 |
| Bachoo, R; Cai, Q; Fan, H; Gao, X; Ge, X; Giannotta, M; Hoyt, K; Li, J; Li, X; Maher, E; Margolis, R; Qin, Z; Vemireddy, V; Xiong, H | 1 |
| Domingo-Diez, J; Guerrero-Martínez, A; Manzaneda-González, V; Megias, D; Ramírez-Castillejo, C; Ramos-Gómez, M; Sánchez-Díez, M; Serrano-Olmedo, J; Souiade, L | 1 |
| Chen, J; Chen, W; Ding, H; Ding, Y; He, C; Li, L; Mo, X; Tang, Q; Wang, Y | 1 |
| Chongsathidkiet, P; Crawford, BM; Cui, X; Dechant, CA; Fecci, PE; Kemeny, HR; Lascola, CD; Liu, Y; Maccarini, PF; Odion, R; Vo-Dinh, T | 1 |
| Garzón Manjón, A; Giesen, B; Janiak, C; Kahlert, UD; Nickel, AC; Scheu, C; Vargas Toscano, A | 1 |
| Cai, X; Cao, X; Lu, G; Ni, Q; Qi, J; Teng, Z; Tian, Y; Wang, D; Wang, S; Zhang, L; Zhu, H | 1 |
| Antoine, R; Bertorelle, F; Fakhouri, H; Gran, ER; Kaul, ES; Maysinger, D; Samhadaneh, DM; Stochaj, U | 1 |
| Choi, YW; Cui, Z; Kim, B; Park, G; Park, SY | 1 |
| Li, S; Liang, J; Liang, Y; Liang, Z; Peng, L; Shi, Y; Tian, Y; Wang, R; Zhang, X; Zhong, X; Zhong, Y | 1 |
| Bourke, P; Byrne, HJ; Cullen, PJ; Curtin, JF; Gunes, S; He, Z; Liu, K; Maher, M; Manaloto, E; Ng, SW; Scally, L; Tian, F; Tiwari, B | 1 |
| Grafals-Ruiz, N; Lozada-Delgado, EL; Martínez-Zayas, G; Noriega-Rivera, RA; Quiñones-Díaz, BI; Rios-Vicil, CI; Santana-Rivera, Y; Santiago-Sánchez, GS; Valiyeva, F; Vivas-Mejía, PE | 1 |
| Courcelle, M; Djaker, N; Palama, T; Sahli, F; Savarin, P; Spadavecchia, J | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Colombatti, M; Colusso, A; Fracasso, G; Litti, L; Meneghetti, M; Pinto, M; Ruli, E; Scarsi, A; Toffoli, G; Ventura, L | 1 |
| Fermi, V; Herold-Mende, C; Roesch, S; Romero-Nieto, C; Rominger, F | 1 |
| Depciuch, J; Maximenko, A; Miszczyk, J; Olko, P; Panek, A; Parlinska-Wojtan, M; Rawojć, K; Zielinski, PM | 1 |
| Dong, CY; Hong, S; Huang, QX; Liu, FS; Zhang, XZ; Zheng, DW; Zhong, ZL | 1 |
| Li, N; Li, Y; Lv, Y; Sha, C; Sun, K; Tang, S; Wang, A; Wang, L; Yan, X; Yu, Y | 1 |
| Athanassiou, A; Calogero, A; Contardi, M; De Sio, L; Guglielmelli, A; Mangino, G; Miglietta, S; Pani, R; Perotto, G; Petrozza, V; Prato, M; Rosa, P | 1 |
| An, Y; Ding, Y; He, C; Hu, C; Liu, D; Tang, Q; Wang, X; Xue, K; Yang, R; Zhang, Z | 1 |
| Chen, MH; Chen, SF; Chiang, CS; Kao, M; Liu, TY; Shih, IJ; Shueng, PW; Zhang, LW | 1 |
| Adams, AK; Antipova, O; Bloch, O; Brat, DJ; Chen, S; Colman, H; Davuluri, RV; Deng, J; Dixit, K; Giles, FJ; Glass, M; Heidel, J; Horbinski, C; Hurley, LA; James, CD; Jovanovic, B; Kandpal, M; Ko, CH; Kouri, FM; Kumthekar, P; Lai, B; Lezon, R; Li, L; Lukas, RV; McCortney, K; Muzzio, M; Paunesku, T; Schwartz, M; Sharma, NV; Sonabend, AM; Stegh, AH; Tate, M; Tommasini-Ghelfi, S; Unruh, D; Vijayakumar, V; Woloschak, GE; Zuckerman, L | 1 |
| Babaei, A; Ghasemi, M; Moattari, A; Mousavi, SM; Pirbonyeh, N; Soleimani, M | 1 |
| Bouché, M; Burdick, JA; Chen, MH; Cormode, DP; Dong, YC; Dorsey, J; Hsu, JC; Salinas, RD; Saxena, D; Sheikh, S; Song, H; Taing, K | 1 |
| Chen, PY; Fadera, S; Lee, IC; Liu, HL | 1 |
| Chen, HZ; Cheng, Q; Liu, JJ; Liu, Y; Liu, ZK; Ni, WW; Song, M; Wang, SS; Wang, YX | 1 |
| Gao, H; He, Q; Hu, C; Rao, J; Ruan, S; Wang, S; Wang, X; Xiao, W; Zhang, H | 1 |
| Chen, L; Fan, K; Gao, X; Hua, W; Li, C; Li, Y; Mao, Y; Qian, J; Yu, Y; Yue, Q; Zhang, R | 1 |
| Feliciano, TJ; Lee, A; Li, W; Odom, TW; Yue, J | 1 |
| Androutsellis-Theotokis, A; Binner, M; Bray, LJ; Gonçalves, DPN; Gür, FN; Jungnickel, C; Kurth, T; Poser, SW; Rodriguez, RD; Schlierf, M; Schmidt, TL; Werner, C; Zahn, DRT | 1 |
| Chen, J; Chen, X; Dai, Y; Fan, Q; Fan, W; Huang, W; Lin, L; Liu, Y; Song, J; Wang, F; Yang, Z; Yu, G; Zhang, F; Zhou, Z | 1 |
| Aiello, I; De Luca, A; Ghedini, M; La Deda, M; Palermo, G; Ricciardi, L; Sancey, L; Strangi, G; Szerb, EI; Termine, R | 1 |
| Choi, J; Kodiha, M; Maysinger, D; Moquin, A; Stochaj, U | 1 |
| Ghaznavi, H; Khateri, M; Neshastehriz, A; Shakeri-Zadeh, A | 1 |
| Ackerley, C; Coluccia, D; Das, S; Diaz, R; Figueiredo, CA; Hynynen, K; Luck, A; O'Reilly, M; Riemenschneider, AN; Rutka, JT; Smith, C; Wu, MY | 1 |
| Gonçalves, DPN; Park, DM; Schmidt, TL; Werner, C | 1 |
| Barcia, C; Byrne, HJ; Casey, A; Conway, GE; Cribaro, GP; Cullen, PJ; Curtin, JF; He, Z; Liu, K; Manaloto, E; Tian, F | 1 |
| Chen, W; Jiang, T; Wang, J; Xu, H; Zhang, F; Zhou, Z | 1 |
| Cho, J; Kang, JH; Ko, YT | 1 |
| Coll, JL; de La Rochefoucauld, O; Henry, M; Josserand, V; Le Guével, X; Longo, E; Montañez, MI; Motto-Ros, V; Pelascini, F; Sancey, L; Zeitoun, P | 1 |
| Battogtokh, G; Gotov, O; Hong, EJ; Kang, JH; Ko, YT; Shim, MS; Shin, D | 1 |
| Kasai, T; Khayrani, AC; Kunoh, H; Kunoh, T; Mahmud, H; Matsumoto, S; Seno, M; Shimura, T; Takada, J | 1 |
| Cianferani, S; da Silva, EC; Dembélé, K; Donzeau, M; Groysbeck, N; Lehmann, M; Stoessel, A; Strub, JM; Zuber, G | 1 |
| Albertini, B; Blasi, P; Donnadio, A; Greco, SML; Iraci, N; Mathieu, V; Ricci, M; Schoubben, A; Temperini, A; Van Woensel, M; Wauthoz, N | 1 |
| Lee, A; Mirkin, CA; Stegh, AH; Tommasini-Ghelfi, S | 1 |
| Afjei, R; Babikir, HA; Bose, RJC; Chang, E; Gambhir, SS; Habte, F; Malhotra, M; Massoud, TF; Paulmurugan, R; Robinson, E; Sinclair, R; Sukumar, UK; Zeng, Y | 1 |
| Biris, AS; Bratu, I; Casciano, D; Florea, A; Florian, S; Olenic, L; Orza, A; Pall, E; Pana, O; Soriţău, O; Tomuleasa, C | 1 |
| Al Zaki, A; Alonso-Basanta, M; Baumann, BC; Bhang, D; Davis, JJ; Dorsey, JF; Joh, DY; Kao, GD; Murty, S; Santoiemma, PP; Stangl, M; Sun, L; Tsourkas, A | 1 |
| Che, Y; Chen, H; Ito, M; Paholak, H; Qian, W; Sansanaphongpricha, K; Sun, D | 1 |
| Cai, X; Wang, L; Wang, LV; Wang, Y; Xia, Y; Zhang, C; Zhang, YS | 1 |
| Ding, D; Li, K; Liu, B; Liu, J; Yuan, Y | 1 |
| Clementi, E; Corti, M; Guari, Y; Larionova, J; Lascialfari, A; Nano, R; Orlando, T; Paolini, A; Pasi, F; Pineider, F; Sacchi, L | 1 |
| Chen, X; Guo, J; Huang, X; Jacobson, O; Kiesewetter, DO; Liu, D; Niu, G; Sun, S; Sun, X; Szajek, LP; Wang, Y; Yan, X; Zhu, W | 1 |
| Cheng, L; Cheng, R; Liu, Z; Meng, F; Wang, C; Zhong, Y; Zhong, Z | 1 |
| Ouberai, M; Piccirillo, SG; Setua, S; Watts, C; Welland, M | 1 |
| Chen, X; Hu, H; Huang, P; Ma, Y; Nie, L; Niu, G; Tang, Y; Weiss, OJ; Wu, K; Yan, X; Yue, X; Zhang, MG | 1 |
| Broome, AM; Dixit, S; Kenney, ME; McKinnon, E; Miller, K; Novak, T; Zhu, Y | 1 |
| Chen, X; Huang, P; Jacobson, O; Lin, L; Ma, Q; Niu, G; Song, J; Yang, X | 1 |
| de la Zerda, A; Gambhir, M; Hussain, Z; Liba, O; SoRelle, ED | 1 |
| Al-Zaki, A; Alonso-Basanta, M; Baumann, BC; Davis, JJ; Dorsey, JF; Joh, DY; Kaol, GD; Murty, S; Stangl, M; Sun, L; Tsourkas, A | 1 |
| Alves, CS; Kong, L; Shi, X; Wu, Y | 1 |
| Kong, L; Qiu, J; Shen, M; Shi, X; Sun, W; Wang, L; Yang, J | 1 |
| Aziz, K; Bhattarai, SR; Chadha, AS; Derry, PJ; Khoo, AM; Krishnan, S; Liopo, A; Singh, PK; Zubarev, ER | 1 |
| Chen, L; Gao, X; Ke, M; Li, C; Li, S; Liu, Z; Mao, Y; Yue, Q; Zhang, J; Zhang, R; Zhou, X | 1 |
| Ananta, JS; Arap, W; Bankson, JA; Bronk, LF; Gelovani, JG; Georgescu, MM; Killian, TC; Levin, CS; Mandelin, J; Molina, JR; Ozawa, MG; Pasqualini, R; Raphael, RM; Souza, GR; Stark, DJ | 1 |
| Agarwal, A; Bellamkonda, RV; El-Sayed, MA; Mackey, MA | 1 |
| del Pozo Guerrero, F; Fernandez Cabada, T; Martinez Serrano, A; Ramos Gomez, M; Sanchez Lopez de Pablo, C; Serrano Olmedo, JJ | 1 |
| Arro, E; Brunk, UT; Collins, VP | 1 |
| McCusker, RH; Sackett, RL | 1 |
1 review(s) available for gold and Glioblastoma
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
2 trial(s) available for gold and Glioblastoma
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma.
Topics: Brain Neoplasms; Glioblastoma; Gold; Humans; Metal Nanoparticles; Muscle Proteins; Neoplasm Recurrence, Local; Nucleic Acids; Proto-Oncogene Proteins c-bcl-2; RNA Interference | 2021 |
83 other study(ies) available for gold and Glioblastoma
| Article | Year |
|---|---|
Radiosensitizing Fe-Au nanocapsules (hybridosomes®) increase survival of GL261 brain tumor-bearing mice treated by radiotherapy.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Gold; Metal Nanoparticles; Mice; Nanocapsules | 2022 |
Plasmon-Triggered Upconversion Emissions and Hot Carrier Injection for Combinatorial Photothermal and Photodynamic Cancer Therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Carriers; Glioblastoma; Gold; Humans; Lanthanoid Series Elements; Materials Testing; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms, Experimental; Optical Imaging; Particle Size; Photochemotherapy; Photosensitizing Agents; Titanium | 2021 |
Radiolabeled Gold Nanoseeds Decorated with Substance P Peptides: Synthesis, Characterization and In Vitro Evaluation in Glioblastoma Cellular Models.
Topics: Cell Line, Tumor; Endocytosis; Glioblastoma; Gold; Humans; Metal Nanoparticles; Models, Biological; Peptides; Radiopharmaceuticals; Serum Albumin; Spectrophotometry, Ultraviolet; Substance P; Transferrin | 2022 |
Efficacy of Temozolomide-Conjugated Gold Nanoparticle Photothermal Therapy of Drug-Resistant Glioblastoma and Its Mechanism Study.
Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Glioblastoma; Gold; Metal Nanoparticles; Mice; Mice, Nude; Pharmaceutical Preparations; Photothermal Therapy; Temozolomide; Xenograft Model Antitumor Assays | 2022 |
Luminescent Pyrrole-Based Phosphaphenalene Gold Complexes: Versatile Anticancer Tools with Wide Applicability.
Topics: Antineoplastic Agents; Brain Neoplasms; Glioblastoma; Gold; Humans; Luminescence; Pyrroles | 2022 |
Bimetallic gold-platinum nanoparticles as a drug delivery system coated with a new drug to target glioblastoma.
Topics: Drug Delivery Systems; Glioblastoma; Gold; HEK293 Cells; Humans; Metal Nanoparticles; Platinum | 2022 |
Intercomparison of radiosensitization induced by gold and iron oxide nanoparticles in human glioblastoma cells irradiated by 6 MV photons.
Topics: Glioblastoma; Gold; Humans; Magnetic Iron Oxide Nanoparticles; Metal Nanoparticles; Photons; Radiation-Sensitizing Agents | 2022 |
Specific nanomarkers fluorescence: in vitro analysis for EGFR overexpressed cells in triple-negative breast cancer and malignant glioblastoma.
Topics: Breast Neoplasms; Cell Line, Tumor; Epidermal Growth Factor; ErbB Receptors; Female; Glioblastoma; Gold; Humans; Metal Nanoparticles; Photochemotherapy; Triple Negative Breast Neoplasms | 2022 |
Mitochondria-targeting nano therapy altering IDH2-mediated EZH2/EZH1 interaction as precise epigenetic regulation in glioblastoma.
Topics: Animals; Brain Neoplasms; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Glioblastoma; Gold; Humans; Isocitrate Dehydrogenase; Metal Nanoparticles; Mice; Mice, Nude; Mitochondria; Polycomb Repressive Complex 2 | 2022 |
Biomimetic Keratin-Coated Gold Nanoparticles for Photo-Thermal Therapy in a 3D Bioprinted Glioblastoma Tumor Model.
Topics: Biomimetic Materials; Glioblastoma; Gold; Humans; Hyperthermia, Induced; Keratins; Metal Nanoparticles; Photothermal Therapy | 2022 |
Gold nanostructure-integrated conductive microwell arrays for uniform cancer spheroid formation and electrochemical drug screening.
Topics: Biosensing Techniques; Drug Evaluation, Preclinical; Early Detection of Cancer; Glioblastoma; Gold; Humans; Spheroids, Cellular | 2023 |
Radiosensitization with Gadolinium Chelate-Coated Gold Nanoparticles Prevents Aggressiveness and Invasiveness in Glioblastoma.
Topics: Cell Line, Tumor; Chelating Agents; Contrast Media; Gadolinium; Glioblastoma; Gold; Humans; Metal Nanoparticles | 2023 |
Spatiotemporal tracking of gold nanorods after intranasal administration for brain targeting.
Topics: Administration, Intranasal; Animals; Brain; Glioblastoma; Gold; Mice; Nanotubes | 2023 |
Photothermal treatment of glioblastoma cells based on plasmonic nanoparticles.
Topics: Cell Line, Tumor; Glioblastoma; Gold; Humans; Hyperthermia, Induced; Metal Nanoparticles; Nanoparticles | 2023 |
Evaluating nanoparticle localisation in glioblastoma multicellular tumour spheroids by surface enhanced Raman scattering.
Topics: Glioblastoma; Gold; Humans; Metal Nanoparticles; Silicon Dioxide; Spectrum Analysis, Raman; Spheroids, Cellular; Tenascin | 2023 |
Evaluation of Radiosensitization and Cytokine Modulation by Differentially PEGylated Gold Nanoparticles in Glioblastoma Cells.
Topics: Cytokines; Glioblastoma; Gold; Humans; Metal Nanoparticles; Polyethylene Glycols | 2023 |
Optical blood-brain-tumor barrier modulation expands therapeutic options for glioblastoma treatment.
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Female; Glioblastoma; Gold; Humans; Metal Nanoparticles; Mice; Nanoparticles; Paclitaxel | 2023 |
Effectiveness of Gold Nanorods of Different Sizes in Photothermal Therapy to Eliminate Melanoma and Glioblastoma Cells.
Topics: Cell Death; Glioblastoma; Gold; Humans; Melanoma; Photothermal Therapy | 2023 |
Gold Nanoparticles Enhance the Ability of Radiotherapy to Induce Immunogenic Cell Death in Glioblastoma.
Topics: Adenosine Triphosphate; Animals; Cell Line, Tumor; Glioblastoma; Gold; HMGB1 Protein; Immunogenic Cell Death; Metal Nanoparticles; Mice | 2023 |
Plasmonic gold nanostar-mediated photothermal immunotherapy for brain tumor ablation and immunologic memory.
Topics: Animals; Brain Neoplasms; Glioblastoma; Gold; Hyperthermia, Induced; Immunologic Memory; Immunotherapy; Laser Therapy; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Nanotechnology; Neoplasms, Experimental; Phototherapy | 2019 |
Influence of synthesis methods on the internalization of fluorescent gold nanoparticles into glioblastoma stem-like cells.
Topics: Brain Neoplasms; Cell Line, Tumor; Chemistry Techniques, Synthetic; Fluorescein-5-isothiocyanate; Glioblastoma; Gold; HEK293 Cells; Humans; Metal Nanoparticles; Organogold Compounds; Polyethyleneimine | 2020 |
Pifithrin-μ incorporated in gold nanoparticle amplifies pro-apoptotic unfolded protein response cascades to potentiate synergistic glioblastoma therapy.
Topics: Brain Neoplasms; Endoplasmic Reticulum Chaperone BiP; Glioblastoma; Gold; Humans; Hyperthermia, Induced; Metal Nanoparticles; Phototherapy; Sulfonamides; Tumor Microenvironment; Unfolded Protein Response | 2020 |
Gold nanoclusters elicit homeostatic perturbations in glioblastoma cells and adaptive changes of lysosomes.
Topics: Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cell Survival; Glioblastoma; Gold; Homeostasis; Humans; Lysosomes; Metal Nanoparticles; NF-E2-Related Factor 2; Particle Size; Proteostasis; Transcription Factors | 2020 |
Treatment with Gold Nanoparticles Using
Topics: Cell Line, Tumor; Cell Movement; Down-Regulation; Glioblastoma; Gold; Green Chemistry Technology; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metal Nanoparticles; Moraceae; Phospholipase D; Plant Extracts; Plant Roots; Tetradecanoylphorbol Acetate | 2020 |
Aptamer-Conjugated Gold Nanoparticles Targeting Epidermal Growth Factor Receptor Variant III for the Treatment of Glioblastoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aptamers, Nucleotide; Brain Neoplasms; Cell Proliferation; ErbB Receptors; Glioblastoma; Gold; Humans; Male; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |
Cold Atmospheric Plasma Stimulates Clathrin-Dependent Endocytosis to Repair Oxidised Membrane and Enhance Uptake of Nanomaterial in Glioblastoma Multiforme Cells.
Topics: Clathrin; Endocytosis; Glioblastoma; Gold; Humans; Metal Nanoparticles; Nanostructures; Nanotechnology; Plasma Gases; Reactive Oxygen Species | 2020 |
Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma.
Topics: Animals; Apolipoproteins E; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Gene Transfer Techniques; Glioblastoma; Gold; Humans; Liposomes; Male; Metal Nanoparticles; Mice, Inbred C57BL; MicroRNAs; Nucleic Acids; Oligonucleotides; RNA Interference; Viral Envelope Proteins; Xenograft Model Antitumor Assays | 2020 |
Temozolomide, Gemcitabine, and Decitabine Hybrid Nanoconjugates: From Design to Proof-of-Concept (PoC) of Synergies toward the Understanding of Drug Impact on Human Glioblastoma Cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Decitabine; Deoxycytidine; Drug Delivery Systems; Drug Liberation; Drug Resistance, Neoplasm; Drug Synergism; Gemcitabine; Glioblastoma; Gold; Humans; Magnetic Resonance Spectroscopy; Metal Nanoparticles; Nanoconjugates; Proof of Concept Study; Spectrophotometry, Ultraviolet; Temozolomide | 2020 |
SERRS multiplexing with multivalent nanostructures for the identification and enumeration of epithelial and mesenchymal cells.
Topics: Epithelial Cells; Glioblastoma; Gold; Humans; Leukocytes, Mononuclear; Male; Mesenchymal Stem Cells; Nanostructures; Prostatic Neoplasms; Spectrum Analysis, Raman; Tumor Cells, Cultured | 2020 |
Gold(i) complexes based on six-membered phosphorus heterocycles as bio-active molecules against brain cancer.
Topics: Apoptosis; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Gold; Heterocyclic Compounds; Humans; Phosphorus | 2020 |
Gold Nanopeanuts as Prospective Support for Cisplatin in Glioblastoma Nano-Chemo-Radiotherapy.
Topics: Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cisplatin; Glioblastoma; Gold; Humans; Metal Nanoparticles; Spectrum Analysis, Raman | 2020 |
Multifunctionalized Gold Sub-Nanometer Particles for Sensitizing Radiotherapy against Glioblastoma.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Gold; Mice | 2021 |
Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting.
Topics: Administration, Intranasal; Animals; Apoptosis; Brain Neoplasms; Cell Line; Cell Line, Tumor; Drug Resistance, Neoplasm; Glioblastoma; Glioma; Gold; Humans; Male; Metal Nanoparticles; Rats; Rats, Sprague-Dawley; Receptor, EphA3; Temozolomide; Xenograft Model Antitumor Assays | 2021 |
Biomimetic keratin gold nanoparticle-mediated
Topics: Biomimetics; Glioblastoma; Gold; Humans; Keratins; Metal Nanoparticles; Photothermal Therapy | 2021 |
LRP1-mediated pH-sensitive polymersomes facilitate combination therapy of glioblastoma in vitro and in vivo.
Topics: Animals; Antibiotics, Antineoplastic; Brain Neoplasms; Cell Line, Tumor; Chemoradiotherapy; Delayed-Action Preparations; Doxorubicin; Drug Delivery Systems; Female; Glioblastoma; Gold; Humans; Hydrogen-Ion Concentration; Low Density Lipoprotein Receptor-Related Protein-1; Metal Nanoparticles; Mice, Inbred BALB C; Mice, Nude; Peptides; Tumor Microenvironment | 2021 |
Tumor cell-targeting radiotherapy in the treatment of glioblastoma multiforme using linear accelerators.
Topics: Brain Neoplasms; Glioblastoma; Gold; Humans; Metal Nanoparticles; Particle Accelerators; Quality of Life | 2021 |
Gold nanoparticles show potential in vitro antiviral and anticancer activity.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Cell Line, Tumor; Cell Migration Assays; Dogs; Glioblastoma; Gold; Humans; Madin Darby Canine Kidney Cells; Metal Nanoparticles | 2021 |
Novel Treatment for Glioblastoma Delivered by a Radiation Responsive and Radiopaque Hydrogel.
Topics: Glioblastoma; Gold; Humans; Hydrogels; Metal Nanoparticles; Neoplasm Recurrence, Local | 2021 |
Induction Therapy of Retinoic Acid with a Temozolomide-Loaded Gold Nanoparticle-Associated Ultrasound Effect on Glioblastoma Cancer Stem-Like Colonies.
Topics: Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Drug Carriers; Drug Liberation; Drug Resistance, Neoplasm; Drug Synergism; Glioblastoma; Gold; Humans; Hyaluronic Acid; Induction Chemotherapy; Metal Nanoparticles; Neoplastic Stem Cells; Spheroids, Cellular; Temozolomide; Tretinoin; Ultrasonic Waves | 2021 |
Imaging asparaginyl endopeptidase (AEP) in the live brain as a biomarker for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Biomarkers; Brain; Cell Line, Tumor; Cognitive Dysfunction; Cysteine Endopeptidases; Disease Models, Animal; Early Diagnosis; Female; Glioblastoma; Glioma; Gold; Humans; Male; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Mice, Transgenic; Plaque, Amyloid | 2021 |
Ligand-Mediated and Enzyme-Directed Precise Targeting and Retention for the Enhanced Treatment of Glioblastoma.
Topics: Animals; Blood-Brain Barrier; Cell Line, Tumor; Doxorubicin; Glioblastoma; Gold; Metal Nanoparticles; Mice | 2017 |
An EGFRvIII targeted dual-modal gold nanoprobe for imaging-guided brain tumor surgery.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; ErbB Receptors; Glioblastoma; Gold; Humans; Magnetic Resonance Imaging; Male; Metal Nanoparticles; Mice, Nude; Neoplasm Transplantation; Surgery, Computer-Assisted | 2017 |
Gold Nanoparticle Size and Shape Effects on Cellular Uptake and Intracellular Distribution of siRNA Nanoconstructs.
Topics: Cell Line, Tumor; Drug Delivery Systems; Endosomes; Glioblastoma; Gold; Humans; Isocitrate Dehydrogenase; Metal Nanoparticles; Microscopy, Electron, Transmission; RNA, Small Interfering; Transfection | 2017 |
Enhanced targeting of invasive glioblastoma cells by peptide-functionalized gold nanorods in hydrogel-based 3D cultures.
Topics: Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Glioblastoma; Gold; Humans; Hydrogels; Nanotubes; Peptides | 2017 |
Self-Assembly of Semiconducting-Plasmonic Gold Nanoparticles with Enhanced Optical Property for Photoacoustic Imaging and Photothermal Therapy.
Topics: Animals; Disease Models, Animal; Electromagnetic Phenomena; Glioblastoma; Gold; Heterografts; Hyperthermia, Induced; Mice; Nanomedicine; Nanoparticles; Neoplasm Transplantation; Optical Imaging; Photoacoustic Techniques; Phototherapy; Polyethylene Glycols; Treatment Outcome | 2017 |
Plasmon-mediated cancer phototherapy: the combined effect of thermal and photodynamic processes.
Topics: Cell Line, Tumor; Glioblastoma; Gold; Humans; Iridium; Luminescence; Metal Nanoparticles; Microscopy, Confocal; Photochemotherapy; Photosensitizing Agents; Phototherapy | 2017 |
Gold nanourchins and celastrol reorganize the nucleo- and cytoskeleton of glioblastoma cells.
Topics: Cell Line, Tumor; Cytoskeleton; Glioblastoma; Gold; Humans; Metal Nanoparticles; Pentacyclic Triterpenes; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; rho-Associated Kinases; Triterpenes | 2018 |
Investigating the Therapeutic Effects of Alginate Nanogel Co-loaded with Gold Nanoparticles and Cisplatin on U87-MG Human Glioblastoma Cells.
Topics: Alginates; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Glioblastoma; Gold; Humans; Metal Nanoparticles; Molecular Structure; Nanogels; Polyethylene Glycols; Polyethyleneimine; Structure-Activity Relationship | 2018 |
Enhancing glioblastoma treatment using cisplatin-gold-nanoparticle conjugates and targeted delivery with magnetic resonance-guided focused ultrasound.
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Cisplatin; Drug Delivery Systems; Female; Glioblastoma; Gold; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Metal Nanoparticles; Mice; Mice, SCID; Microscopy, Confocal; Ultrasonic Waves | 2018 |
Modular peptide-functionalized gold nanorods for effective glioblastoma multicellular tumor spheroid targeting.
Topics: Antineoplastic Agents; Apoptosis; Endocytosis; Glioblastoma; Gold; Humans; Metal Nanoparticles; Nanotubes; Neoplastic Stem Cells; Nestin; Polyethylene Glycols; Spheroids, Cellular; Tumor Cells, Cultured | 2018 |
Cold Atmospheric Plasma Induces ATP-Dependent Endocytosis of Nanoparticles and Synergistic U373MG Cancer Cell Death.
Topics: Adenosine Triphosphate; Cell Death; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Endocytosis; Glioblastoma; Gold; Humans; Metal Nanoparticles; Plasma Gases; Protein Corona; Reactive Oxygen Species | 2018 |
A novel nanocomposite based on fluorescent turn-on gold nanostars for near-infrared photothermal therapy and self-theranostic caspase-3 imaging of glioblastoma tumor cell.
Topics: Apoptosis; Caspase 3; Fluorescence; Fluorescent Dyes; Glioblastoma; Gold; Humans; Metal Nanoparticles; Nanocomposites; Particle Size; Phototherapy; Surface Properties; Theranostic Nanomedicine; Tumor Cells, Cultured | 2018 |
Investigation on the effect of nanoparticle size on the blood-brain tumour barrier permeability by in situ perfusion via internal carotid artery in mice.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Neoplasms; Carotid Artery, Internal; Drug Delivery Systems; Glioblastoma; Gold; Humans; Male; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Particle Size; Permeability; Xenograft Model Antitumor Assays | 2019 |
Elemental and optical imaging evaluation of zwitterionic gold nanoclusters in glioblastoma mouse models.
Topics: Animals; Cell Line, Tumor; Contrast Media; Female; Glioblastoma; Gold; Humans; Metal Nanoparticles; Mice; Mice, Nude; Neoplasms, Experimental; Tomography, Optical; Tomography, X-Ray | 2018 |
Glycol chitosan-coated near-infrared photosensitizer-encapsulated gold nanocages for glioblastoma phototherapy.
Topics: Animals; Cell Line, Tumor; Chitosan; Endocytosis; Glioblastoma; Gold; Humans; Infrared Rays; Metal Nanoparticles; Mice, Inbred BALB C; Mice, Nude; Peptides; Photosensitizing Agents; Phototherapy; Proton Magnetic Resonance Spectroscopy; Tissue Distribution | 2019 |
Use of DNA-generated gold nanoparticles to radiosensitize and eradicate radioresistant glioma stem cells.
Topics: Annexins; Apoptosis; Cell Line, Tumor; DNA; DNA Damage; Fluorescent Dyes; Glioblastoma; Glioma; Gold; Histones; Humans; Metal Nanoparticles; Mitosis; Neoplastic Stem Cells; Radiation Tolerance; Reactive Oxygen Species | 2019 |
Synthesis and biological evaluation of 2.4 nm thiolate-protected gold nanoparticles conjugated to Cetuximab for targeting glioblastoma cancer cells via the EGFR.
Topics: Cell Line, Tumor; Cetuximab; Drug Delivery Systems; ErbB Receptors; Glioblastoma; Gold; Humans; Metal Nanoparticles; Neoplasm Proteins; Particle Size | 2019 |
Tumor Targeting by Peptide-Decorated Gold Nanoparticles.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Flow Cytometry; Glioblastoma; Gold; Integrin alphaVbeta3; Melanoma; Metal Nanoparticles; Mice; Nanomedicine; Polyethylene Glycols | 2019 |
Synthesis, Physicochemical, and Biological Evaluation of Spherical Nucleic Acids for RNAi-Based Therapy in Glioblastoma.
Topics: Animals; Gene Silencing; Glioblastoma; Gold; Humans; Mice; Nanoparticles; Nucleic Acids; Oligonucleotides; RNA, Small Interfering; RNAi Therapeutics | 2019 |
Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide.
Topics: Animals; beta-Cyclodextrins; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Drug Resistance, Neoplasm; Ferric Compounds; Glioblastoma; Gold; Humans; Mice; MicroRNAs; Temozolomide; Theranostic Nanomedicine; Xenograft Model Antitumor Assays | 2019 |
Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles.
Topics: Analysis of Variance; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aspartic Acid; Cell Survival; Cells, Cultured; Dacarbazine; Drug Delivery Systems; Drug Resistance, Neoplasm; Drug Stability; Drug Synergism; Flow Cytometry; Glioblastoma; Gold; Humans; Metal Nanoparticles; Microscopy, Electron, Transmission; Neoplastic Stem Cells; Temozolomide | 2013 |
Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization.
Topics: Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Female; Glioblastoma; Gold; Mice; Mice, Nude; Nanoparticles | 2013 |
'Living' PEGylation on gold nanoparticles to optimize cancer cell uptake by controlling targeting ligand and charge densities.
Topics: Biological Transport; Cell Line, Tumor; Drug Delivery Systems; Glioblastoma; Gold; Humans; Macrophages; Nanoparticles; Oligopeptides; Polyethylene Glycols | 2013 |
Labeling human mesenchymal stem cells with gold nanocages for in vitro and in vivo tracking by two-photon microscopy and photoacoustic microscopy.
Topics: Animals; Cell Differentiation; Cell Survival; Cell Tracking; Contrast Media; Glioblastoma; Gold; Humans; Mesenchymal Stem Cells; Metal Nanoparticles; Mice; Mice, Nude; Microscopy; Microscopy, Acoustic; Photons | 2013 |
Tumor-responsive fluorescent light-up probe based on a gold nanoparticle/conjugated polyelectrolyte hybrid.
Topics: Cell Line, Tumor; Contrast Media; Electrolytes; Fluorescent Dyes; Glioblastoma; Gold; Humans; Image Enhancement; Materials Testing; Metal Nanoparticles; Microscopy, Fluorescence; Polymers | 2014 |
NMR as evaluation strategy for cellular uptake of nanoparticles.
Topics: Antineoplastic Agents, Alkylating; Cell Line, Tumor; Dacarbazine; Ferric Compounds; Glioblastoma; Gold; Humans; Magnetic Resonance Spectroscopy; Nanoparticles; Rhamnose; Temozolomide | 2014 |
Chelator-free (64)Cu-integrated gold nanomaterials for positron emission tomography imaging guided photothermal cancer therapy.
Topics: Animals; Cell Line, Tumor; Copper; Copper Radioisotopes; Glioblastoma; Gold; Humans; Mice; Nanostructures; Nanotubes; Oligopeptides; Oxidation-Reduction; Phototherapy; Polyethylene Glycols; Positron-Emission Tomography; Tissue Distribution | 2014 |
cRGD-directed, NIR-responsive and robust AuNR/PEG-PCL hybrid nanoparticles for targeted chemotherapy of glioblastoma in vivo.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Doxorubicin; Drug Carriers; Glioblastoma; Gold; Humans; Mice, Nude; Nanoparticles; Nanotubes; Oligopeptides; Polyesters; Polyethylene Glycols; Tissue Distribution; Xenograft Model Antitumor Assays | 2014 |
Cisplatin-tethered gold nanospheres for multimodal chemo-radiotherapy of glioblastoma.
Topics: Apoptosis; Caspases; Cell Line, Tumor; Cisplatin; DNA Damage; Gamma Rays; Glioblastoma; Gold; Histones; Humans; Nanospheres; Polyethyleneimine; Radiation-Sensitizing Agents | 2014 |
PET and NIR optical imaging using self-illuminating (64)Cu-doped chelator-free gold nanoclusters.
Topics: Animals; Cell Line, Tumor; Copper; Glioblastoma; Gold; Humans; Infrared Rays; Isotopes; Mice; Nanostructures; Optical Imaging; Positron-Emission Tomography | 2014 |
Dual Receptor-Targeted Theranostic Nanoparticles for Localized Delivery and Activation of Photodynamic Therapy Drug in Glioblastomas.
Topics: Animals; Drug Carriers; Drug Delivery Systems; ErbB Receptors; Glioblastoma; Gold; Humans; Indoles; Metal Nanoparticles; Mice; Mice, Nude; Molecular Targeted Therapy; Peptide Fragments; Photochemotherapy; Photosensitizing Agents; Receptors, Transferrin; Theranostic Nanomedicine; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
Sequential Drug Release and Enhanced Photothermal and Photoacoustic Effect of Hybrid Reduced Graphene Oxide-Loaded Ultrasmall Gold Nanorod Vesicles for Cancer Therapy.
Topics: Animals; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Liberation; Glioblastoma; Gold; Graphite; Humans; Mice; Nanotubes; Phototherapy; Positron-Emission Tomography; Xenograft Model Antitumor Assays | 2015 |
Biofunctionalization of Large Gold Nanorods Realizes Ultrahigh-Sensitivity Optical Imaging Agents.
Topics: Animals; Biotin; Cell Line, Tumor; Contrast Media; Ear; Female; Glioblastoma; Gold; Light; Mice; Mice, Inbred C57BL; Mice, Nude; Nanotubes; Neoplasm Transplantation; Optical Imaging; Particle Size; Polyethylene Glycols; Scattering, Radiation; Streptavidin | 2015 |
Theranostic Application of Mixed Gold and Superparamagnetic Iron Oxide Nanoparticle Micelles in Glioblastoma Multiforme.
Topics: Administration, Intravenous; Animals; Brain Neoplasms; Cell Line, Tumor; Contrast Media; Dextrans; Glioblastoma; Gold; Humans; Magnetic Resonance Imaging; Magnetite Nanoparticles; Mice; Micelles; Nanoparticles; Radiation Tolerance; Theranostic Nanomedicine; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays | 2016 |
Efficient delivery of therapeutic siRNA into glioblastoma cells using multifunctional dendrimer-entrapped gold nanoparticles.
Topics: Animals; Cell Line, Tumor; Dendrimers; Drug Delivery Systems; Drug Liberation; Gene Silencing; Glioblastoma; Gold; Humans; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Oligopeptides; Particle Size; Polyethylene Glycols; RNA, Small Interfering; Transfection | 2016 |
Multifunctional PEI-entrapped gold nanoparticles enable efficient delivery of therapeutic siRNA into glioblastoma cells.
Topics: Antineoplastic Agents; Cell Proliferation; Cell Survival; Drug Delivery Systems; Genetic Therapy; Glioblastoma; Gold; Humans; Metal Nanoparticles; Microscopy, Confocal; Polyethyleneimine; RNA, Small Interfering; Tumor Cells, Cultured | 2017 |
Gold nanotriangles: scale up and X-ray radiosensitization effects in mice.
Topics: Animals; Glioblastoma; Gold; Humans; Male; MCF-7 Cells; Metal Nanoparticles; Mice; Radiation-Sensitizing Agents; X-Rays; Xenograft Model Antitumor Assays | 2017 |
Guiding Brain-Tumor Surgery via Blood-Brain-Barrier-Permeable Gold Nanoprobes with Acid-Triggered MRI/SERRS Signals.
Topics: Blood-Brain Barrier; Brain Neoplasms; Glioblastoma; Gold; Humans; Magnetic Resonance Imaging; Nanostructures | 2017 |
Three-dimensional tissue culture based on magnetic cell levitation.
Topics: Astrocytes; Cell Line, Tumor; Ferrosoferric Oxide; Glioblastoma; Gold; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Inovirus; Magnetics; Microscopy, Fluorescence; Proteins; Tissue Culture Techniques | 2010 |
Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Delivery Systems; Female; Glioblastoma; Gold; Humans; Liposomes; Metal Nanoparticles; Mice; Mice, Nude; Nanostructures; Neoplasms; Polyethylene Glycols | 2011 |
Induction of cell death in a glioblastoma line by hyperthermic therapy based on gold nanorods.
Topics: Caspase 3; Cell Death; Cell Line, Tumor; Cell Survival; Glioblastoma; Gold; Humans; Hyperthermia, Induced; L-Lactate Dehydrogenase; Laser Therapy; Metal Nanoparticles; Microscopy, Electron, Transmission; Nanomedicine; Surface Plasmon Resonance | 2012 |
High resolution SEM of cultured cells: preparatory procedures.
Topics: Cell Line; Cell Membrane; Cells, Cultured; Cytological Techniques; Fixatives; Glioblastoma; Glutaral; Gold; Humans; Hydrolyzable Tannins; Microscopy, Electron, Scanning; Microvilli; Osmium Tetroxide; Palladium | 1981 |
Multivalent cations depress ligand binding to cell-associated insulin-like growth factor binding protein-5 on human glioblastoma cells.
Topics: Affinity Labels; Cadmium; Cations; Chromium; Dose-Response Relationship, Drug; Glioblastoma; Gold; Humans; Insulin; Insulin-Like Growth Factor Binding Protein 5; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Lanthanum; Tumor Cells, Cultured; Zinc | 1998 |